Stay updated on Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The history now shows Revision: v3.4.3 and removes Revision: v3.4.2. This is a minor version update to the history display.
    Difference
    0.0%
    Check dated 2026-03-11T17:39:35.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    A new version entry was added showing a recruitment status update to the trial record history.
    Difference
    0.0%
    Check dated 2026-02-25T10:17:59.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    The page history now shows a new revision labeled v3.4.2, and the notices about government funding and the older v3.4.1 revision were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T06:21:19.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    A site-wide maintenance notice about government funding status and a new site version (v3.4.1) were added, replacing the previous v3.4.0. No study-specific content or data appear to be altered.
    Difference
    0.3%
    Check dated 2026-02-04T04:42:33.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    UI updates include showing the glossary and color-coded change highlights (green for additions, red for deletions) along with a new Revision: v3.4.0. The label 'No FEAR Act Data' has been updated (capitalization) and the previous v3.3.4 revision text was removed.
    Difference
    0.4%
    Check dated 2026-01-28T01:52:33.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Added Revision: v3.3.4 and removed Revision: v3.3.3.
    Difference
    0.0%
    Check dated 2026-01-14T00:40:20.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial page.